3 . 2024

Laparoscopic correction of recurrent hiatal hernia after LINX system implantation. Clinical case

Abstract

The clinical case presented in this article illustrates the first clinical case of using the LINX system in a patient with recurrent GERD and HH after primary magnetic augmentation of the lower esophageal sphincter described in domestic literature. A 53-year-old patient underwent a revision surgery for recurrent hernia, compression of the esophageal-gastric junction in the area of a previously installed metal magnetic prosthesis, and severe dysphagia. Surgical intervention was performed in the scope of laparoscopic removal of the LINX magnetic system and Chernousov fundoplication. Control postoperative X-ray examination with oral contrast showed a good functional result.

Considering the smooth course of the postoperative period and the absence of early postoperative complications, the patient was discharged in a satisfactory condition on the 4^th postoperative day. The control examination data in 3 months after surgical treatment showed a pronounced improvement in the quality of life in the postoperative period.

Keywords: hiatal hernia; gastroesophageal reflux disease; laparoscopic fundoplication; LINX system; lower esophageal sphincter; magnetic sphincter augmentation

Funding. The study had no sponsor support.

Conflict of interest. The authors declare no conflict of interest.

For citation: Galliamov E.A., Erin S.A., Gololobov G.Yu., Gadlevsky G.S., Ovchinnikova U.R., Abumuslimov K.K. Laparoscopic correction of recurrent hiatal hernia after LINX system implantation. Clinical case. Clinical and Experimental Surgery. Petrovsky Journal. 2024; 12 (3): 96–103. DOI: https://doi.org/10.33029/2308-1198-2024-12-3-96-103 (in Russian)

References

1. Hunt R., Armstrong D., Katelaris P., Afihene M., et al.; Review Team. World Gastroenterology Organisation Global Guidelines: GERD Global perspective on gastroesophageal reflux disease. J Clin Gastroenterol. 2017; 51 (6): 467–78. DOI: https://doi.org/10.1097/MCG.0000000000000854 PMID: 28591069.

2. Ganz R.A. A modern magnetic implant for gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2017; 15 (9): 1326–37. DOI: https://doi.org/10.1016/j.cgh.2016.12.019 Epub 2016 Dec 24. PMID: 28025156.

3. Louie B.E., Smith C.D., Smith C.C., Bell R.C.W., et al. Objective evidence of reflux control after magnetic sphincter augmentation: one-year results from a post approval study. Ann Surg. 2019; 270 (2): 302–8. DOI: https://doi.org/10.1097/SLA.0000000000002789 PMID: 29697454.

4. Ganz R.A., Peters J.H., Horgan S., Bemelman W.A., Dunst C.M., Edmundowicz S.A., et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013; 368 (8): 719–27. DOI: https://doi.org/10.1056/NEJMoa1205544 PMID: 23425164.

5. Katz P.O., Dunbar K.B., Schnoll-Sussman F.H., Greer K.B., Yadlapati R., Spechler S.J. ACG Clinical Guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022; 117 (1): 27–56. DOI: https://doi.org/10.14309/ajg.0000000000001538 PMID: 34807007; PMCID: PMC8754510.

6. Friedel D. Potential role of new technological innovations in nonvariceal hemorrhage. World J Gastrointest Endosc. 2019; 11 (8): 443–53. DOI: https://doi.org/10.4253/wjge.v11.i8.443 PMID: 31523376; PMCID: PMC6715570.

7. Buckley F.P. 3rd, Bell R.C.W., Freeman K., Doggett S., Heidrick R. Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation. Surg Endosc. 2018; 32 (4): 1762–8. DOI: https://doi.org/10.1007/s00464-017-5859-4 Epub 2017 Sep 21. PMID: 28936790; PMCID: PMC5845067.

8. Kohn G.P., Price R.R., DeMeester S.R., Zehetner J., et al.; SAGES Guidelines Committee. Guidelines for the management of hiatal hernia. Surg Endosc. 2013; 27 (12): 4409–28. DOI: https://doi.org/10.1007/s00464-013-3173-3 Epub 2013 Sep 10. PMID: 24018762.

9. Bonavina L., Saino G.I., Bona D., Lipham J., Ganz R.A., Dunn D., et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg. 2008; 12 (12): 2133–40. DOI: https://doi.org/10.1007/s11605-008-0698-1 Epub 2008 Oct 10. PMID: 18846406.

10. Bonavina L., DeMeester T., Fockens P., Dunn D., Saino G., Bona D., et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg. 2010; 252 (5): 857–62. DOI: https://doi.org/10.1097/SLA.0b013e3181fd879b PMID: 21037442.

11. Aiolfi A., Asti E., Bernardi D., Bonitta G., Rausa E., Siboni S., et al. Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis. Int J Surg. 2018; 52: 82–8. DOI: https://doi.org/10.1016/j.ijsu.2018.02.041 Epub 2018 Feb 20. PMID: 29471155.

12. Chen M.Y., Huang D.Y., Wu A., Zhu Y.B., Zhu H.P., Lin L.M., et al. Efficacy of magnetic sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease in short term: a meta-analysis. Can J Gastroenterol Hepatol. 2017; 2017: 9596342. DOI: https://doi.org/10.1155/2017/9596342 Epub 2017 Mar 30. PMID: 28466002; PMCID: PMC5390656.

13. Guidozzi N., Wiggins T., Ahmed A.R., Hanna G.B., Markar S.R. Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis. Dis Esophagus. 2019; 32 (9): doz031. DOI: https://doi.org/10.1093/dote/doz031 PMID: 31069388.

14. Lipham J.C., Taiganides P.A., Louie B.E., Ganz R.A., DeMeester T.R. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2015; 28 (4): 305–11. DOI: https://doi.org/10.1111/dote.12199 Epub 2014 Mar 11. PMID: 24612509.

15. Riegler M., Schoppman S.F., Bonavina L., Ashton D., Horbach T., Kemen M. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2015; 29 (5): 1123–9. DOI: https://doi.org/10.1007/s00464-014-3772-7 Epub 2014 Aug 30. PMID: 25171881.

16. Warren H.F., Reynolds J.L., Lipham J.C., Zehetner J., Bildzukewicz N.A., Taiganides P.A., et al. Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc. 2016; 30 (8): 3289–96. DOI: https://doi.org/10.1007/s00464-015-4659-y Epub 2015 Nov 5. PMID: 26541740.

17. Asti E., Bonitta G., Lovece A., Lazzari V., Bonavina L. Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation: observational cohort study with propensity score analysis. Medicine (Baltimore). 2016; 95 (30): e4366. DOI: https://doi.org/10.1097/MD.0000000000004366 PMID: 27472725; PMCID: PMC5265862.